Biosensing Team Twente 2023/2024
We are a team of 12 individuals from different backgrounds and studies.
Danail Tsanov
Team Captain
Business
Caterina Cattabriga
Team Captain
Research
Alex Faloppa
Experiment and Analysis
Danila Bren
Experiment and Analysis
Hanna Lücking
Marketing
Janine Ferro
Chip Design
Julia Paredes
Experiment and Analysis
Ken Heng
Device Design
Marisa Paiva Silva
Experiment and Analysis
Pelin Akça
Chip Design
Vinaya Tennakoon
Chemistry
Xavier Mourelo Garcia
Device Design
Coaches, Board and Supervisors
Roman Koval
Chairman and Founder
Diana Andreoli
Secretary of the Board and Founder
Jan Pieter de Rie
Treasurer of the Board and Founder
Thomas Martens
Founder
Rory Timmerman
Technical Advisor
Dr. Ir. Pep Canyelles Pericas
Research Coordinator, Supervisory Board
Dr. Ir. Nico Overeem
Research Coordinator, Supervisory Board
Mohammad Saghafi MSc
Research Coordinator, Supervisory Board
Amarna Pals MSc
Supervisory Board
At Biosensing Team Twente, we participated in the Sensus Competition 2024, an international challenge focused on developing cutting-edge biosensors for real-time health monitoring. This year’s competition aimed at designing an innovative creatinine sensor for early detection of Acute Kidney Injury (AKI).
The Creatinine Sensor
Our sensor was designed to continuously monitor creatinine levels in interstitial fluid (ISF) using a hollow microneedle system. It integrated:
- Aptamer-based electrochemical sensing for high specificity.
- A microfluidic flow cell to extract ISF efficiently.
- Electrochemical signal processing to measure creatinine concentrations in real-time.
Why Detect Creatinine?
Creatinine is a key biomarker for kidney function. High levels in blood or ISF indicate impaired kidney filtration, which can be a sign of Acute Kidney Injury (AKI)—a severe condition where the kidneys suddenly fail to remove waste from the body. Early detection is critical to prevent long-term damage or fatal complications.
Competition Goal
- Accurately detect creatinine at clinically relevant levels.
- Ensure real-time, continuous monitoring without external lab equipment.
By participating in Sensus 2024, we contributed to the future of wearable, non-invasive kidney health monitoring—a crucial step toward personalized and preventive medicine.
